Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


RENAL FUNCTION OF MICE WITH TARGETED DISRUPTION OF THE A-ISOFORM OF THE NA/K/2CL-COTRANSPORTER NKCC2
Abstract number: O03-6

Castrop1 H, Oppermann1 M, Mizel1 D, Huang1 Y, Deng1 C, Briggs1 J, Schnermann1 J

1Institute of Physiology, University of Regensburg

Three different splice-isoforms of the Na/K/2Cl cotransporter, NKCC2, are expressed along the thick ascending limb of Henle: NKCC2A, NKCC2B, and NKCC2F. The reason for the existence of 3 different NKCC2 isoforms is unclear. To address the role of NKCC2A in kidney function we generated NKCC2A-/- mice. Ambient urine osmolarity was lower in NKCC2A-/- mice (1384±98 mosm/l; n=15) compared to WT (1910±173 mosm/l; n=14; p=.012), but urinary concentrating ability after water restriction was preserved. Baseline plasma renin concentration (PRC) was similar in NKCC2A-/- (640±85 ng Ang I/ml/hr; n=20) and +/+ mice (629±79 ng Ang I/ml/hr; n=19; p=.92). However, the suppression of PRC after acute salt loading (saline, i.v.), as a measure of macula densa-mediated suppression of renin secretion was only -16±2% in NKCC2A-/- mice (n=17; p=.14 vs. basal) compared to -42±6% in WT (n=13; p=.006 vs. basal). Chronic high salt intake, conversely, suppressed PRC similarly in both genotypes. Maximum tubuloglomerular feedback responses as determined by stop flow pressure (PSF) measurements were significantly reduced in NKCC2A-/- (PSF=-16±2%) compared to WT (PSF=-26±3%; p=.016). In summary, NKCC2A-deficient mice are viable and show no severe salt-losing phenotype. However, NKCC2A activity seems to be crucially involved in macula densa salt sensing in the high Cl concentration range.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :O03-6

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE